What is the recommended diagnostic work‑up and treatment for a teenager or young adult presenting with progressive deep bone pain, worse at night, and a palpable knee mass suspicious for osteosarcoma?

Osteosarcoma: Diagnostic Work-up and Treatment

A teenager or young adult with progressive deep bone pain worse at night and a palpable knee mass suspicious for osteosarcoma requires immediate referral to a specialized bone sarcoma center for biopsy and staging, followed by multimodal treatment consisting of neoadjuvant chemotherapy (doxorubicin, cisplatin, high-dose methotrexate ± ifosfamide) and limb-salvage surgery with wide margins, which increases disease-free survival from <20% to >60% compared to surgery alone. 1

Initial Diagnostic Work-up

Clinical Presentation Recognition

• Persistent non-mechanical bone pain, predominantly at night, is the hallmark symptom that should prompt immediate radiological assessment 1
• Pain is often initially intermittent and may be confused with growing pains, leading to diagnostic delays averaging 10-20 weeks 2, 3
• Swelling appears later (average 7 weeks after pain onset) when tumor has progressed through cortex 3
• A palpable mass indicates extracompartmental extension 3
• Functional impairment and limp occur in 67% of patients 3

Imaging Protocol

Start with conventional radiographs in two planes - this is the primary diagnostic modality showing cortical destruction and irregular reactive bone formation 1

Proceed immediately to MRI of the entire compartment with adjacent joints if malignancy cannot be excluded on radiographs - this is the gold standard for local staging of extremity tumors 1

Complete staging work-up includes: 1

• High-resolution spiral chest CT (lung is the most common metastatic site) 1
• Bone scintigraphy and/or whole-body MRI to detect skip metastases and distant bone involvement 1
• Consider FDG-PET/CT for comprehensive staging 1

Laboratory Evaluation

Baseline blood work must include: 1

• Alkaline phosphatase (AP) and lactate dehydrogenase (LDH) - elevated levels correlate with adverse outcomes and metastatic disease 1
• Complete blood count with differential 1
• Comprehensive metabolic panel including magnesium, phosphate, renal and liver function 1
• Coagulation profile and blood group typing 1

Pre-treatment cardiac and auditory assessment is mandatory: 1

• Echocardiogram or radionuclide ventriculography (chemotherapy causes cardiac dysfunction) 1
• Audiogram (cisplatin and platinum derivatives cause auditory toxicity) 1

Fertility preservation counseling is essential: 1

• Sperm storage recommended for male patients of reproductive age 1
• Female patients should consult fertility specialists regarding ovarian sampling, cryopreservation, and gonadotropin-releasing hormone agonists 1

Biopsy Requirements

Critical principle: The biopsy MUST be performed at the reference bone sarcoma center by the surgical team that will perform definitive resection or by a dedicated interventional radiologist 1

• Core-needle biopsy under imaging guidance is appropriate in most patients as an alternative to open biopsy 1
• The biopsy tract must be marked (small incision or ink tattoo) as it will be excised en bloc with the tumor to minimize local recurrence risk 1
• Multiple samples from representative areas are mandatory 1
• If open biopsy is required, use longitudinal incision only 1

Common pitfall: Performing biopsy at a non-specialized center contaminates tissue planes and compromises subsequent limb-salvage surgery 1

Treatment Strategy

Referral to Specialized Center

Patients must be treated at reference centers or within reference networks with access to the full spectrum of care and age-specific expertise 1

• Treatment within prospective multi-institutional trials or established protocols is standard 1
• Pediatric and adolescent patients require surgeons experienced in age-specific reconstruction challenges including growing bone reconstruction 1

Multimodal Treatment for High-Grade Osteosarcoma

Curative treatment consists of chemotherapy and surgery - this combination increases disease-free survival from <20% to >60% compared to surgery alone 1

Chemotherapy Regimen

The MAP regimen (doxorubicin/cisplatin/high-dose methotrexate) is most frequently used as front-line therapy in children and young adults: 1

• Doxorubicin, cisplatin, high-dose methotrexate with leucovorin rescue, and ifosfamide are the most active agents 1
• Treatment duration is typically 6-12 months 1
• High-dose methotrexate requires meticulous adherence to protocol-specific recommendations due to toxicity 1

Neoadjuvant chemotherapy is administered before surgery: 1

• While preoperative chemotherapy has not been proven to improve survival compared to postoperative chemotherapy alone, it allows assessment of histological response which is a critical prognostic factor 1
• Good histological response (>90% tumor necrosis) predicts improved survival 1

Important caveat: In patients >40 years, high-dose methotrexate can be challenging to administer; regimens combining doxorubicin, cisplatin, and potentially ifosfamide are alternatives 1

Surgical Management

Limb-salvage surgery is the preferred approach if wide surgical margins can be achieved 1

Critical surgical principles: 1

• Clear (R0) margins are the primary goal - R1 and R2 margins increase local recurrence and reduce overall survival 1
• Wide margins by Enneking's definition required: complete tumor removal including biopsy tract surrounded by unviolated cuff of normal tissue 1
• Areas of suspected close margins must be marked on surgical specimen for pathology 1
• Most patients should be considered candidates for limb salvage 1

Amputation is reserved for: 1

• Tumors in unfavorable anatomic locations not amenable to limb-sparing surgery with adequate margins 1
• Cases where limb salvage would compromise oncologic safety 1

Management of pathological fracture: 1

• Internal fixation is contraindicated - it disseminates tumor into bone and soft tissues, increasing local recurrence risk 1
• External splintage is recommended 1
• Pathological fracture does not necessarily require amputation - neoadjuvant chemotherapy allows fracture hematoma to contract, enabling subsequent resection 1

Radiotherapy

Radiotherapy has a very limited role in extremity osteosarcoma and should be reserved for inoperable situations or axial locations where radical surgery is not feasible 1

Prognostic Factors

Adverse prognostic factors include: 1

• Proximal extremity or axial tumor site 1
• Large tumor volume 1
• Elevated serum AP or LDH 1
• Detectable primary metastases (most important factor) 1
• Poor histological response to preoperative chemotherapy (<90% necrosis) 1

Favorable prognostic factors: 1

• Female sex (associated with increased chemotherapy-induced tumor necrosis and greater overall survival) 1
• Distal extremity location 1
• Good histological response to neoadjuvant chemotherapy 1

Common Pitfalls to Avoid

1. Delayed diagnosis: Night pain in adolescents with knee symptoms should never be dismissed as growing pains - 20% of patients have negative initial radiographs leading to 54-day diagnostic delays 2, 3

2. Biopsy at non-specialized center: This contaminates tissue planes and compromises limb salvage 1

3. Inadequate staging before biopsy: Complete imaging work-up must precede biopsy to determine optimal biopsy approach and sampling areas 1

4. Internal fixation of pathological fracture: This is contraindicated and increases local recurrence risk 1

5. Failure to refer to specialized center: Treatment at specialized centers, particularly for adolescents, is associated with improved outcomes 1